Evidence map›Paper›PMID 33665333›Full record

ArticleSSM - population health2021

Low uptake of COVID-19 prevention behaviours and high socioeconomic impact of lockdown measures in South Asia: Evidence from a large-scale multi-country surveillance programme.

Dian Kusuma, Rajendra Pradeepa, Khadija I Khawaja, Mehedi Hasan, Samreen Siddiqui, Sara Mahmood, Syed Mohsin Ali Shah, Chamini K De Silva, Laksara de Silva, Manoja Gamage and 24 more

Abstract read
In one paragraph

Article in SSM - population health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Dian KusumaCentre for Health Economics & Policy Innovation, Imperial College Business School, UK.
Rajendra PradeepaMadras Diabetes Research Foundation, Chennai, India.
Khadija I KhawajaServices Institute of Medical Sciences, Lahore, Pakistan.
Mehedi HasanBRAC James P Grant School of Public Health, BRAC University, Dhaka, Bangladesh.
Samreen SiddiquiMax Healthcare, New Delhi, India.
Sara MahmoodServices Institute of Medical Sciences, Lahore, Pakistan.
Syed Mohsin Ali ShahPunjab Institute of Cardiology, Lahore, Pakistan.
Chamini K De SilvaFaculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Laksara de SilvaFaculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Manoja GamageFaculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Menka LoombaMax Healthcare, New Delhi, India.
Vindya P RajakarunaFaculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Abu Am HanifBRAC James P Grant School of Public Health, BRAC University, Dhaka, Bangladesh.
Rajan Babu KamaleshMadras Diabetes Research Foundation, Chennai, India.
Balachandran KumarendranFaculty of Medicine, University of Jaffna, Jaffna, Sri Lanka.
Marie LohLee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Archa MisraMax Healthcare, New Delhi, India.
Asma TassawarPunjab Institute of Cardiology, Lahore, Pakistan.
Akansha TyagiMax Healthcare, New Delhi, India.
Swati WaghdhareMax Healthcare, New Delhi, India.
Saira BurneyServices Institute of Medical Sciences, Lahore, Pakistan.
Sajjad AhmadPunjab Institute of Cardiology, Lahore, Pakistan.
Viswanathan MohanMadras Diabetes Research Foundation, Chennai, India.
Malabika SarkerBRAC James P Grant School of Public Health, BRAC University, Dhaka, Bangladesh.
Ian Y GoonSchool of Public Health, Imperial College London, London, UK.
Anuradhani KasturiratneFaculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Jaspal S KoonerNational Heart and Lung Institute, Imperial College London, London, UK.
Prasad KatulandaFaculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Sujeet JhaMax Healthcare, New Delhi, India.
Ranjit Mohan AnjanaMadras Diabetes Research Foundation, Chennai, India.
Malay K MridhaBRAC James P Grant School of Public Health, BRAC University, Dhaka, Bangladesh.
Franco SassiCentre for Health Economics & Policy Innovation, Imperial College Business School, UK.
John C ChambersLee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
NIHR Global Health Research Unit for Diabetes and Cardiovascular Disease in South Asia

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundSouth Asia has become a major epicentre of the COVID-19 pandemic. Understanding South Asians' awareness, attitudes and experiences of early measures for the prevention of COVID-19 is key to improving the effectiveness and mitigating the social and economic impacts of pandemic responses at a critical time for the Region.

methodsWe assessed the knowledge, behaviours, health and socio-economic circumstances of 29,809 adult men and women, at 93 locations across four South Asian countries. Data were collected during the national lockdowns implemented from March to July 2020, and compared with data collected prior to the pandemic as part of an ongoing prospective surveillance initiative.

resultsParticipants were 61% female, mean age 45.1 years. Almost half had one or more chronic disease, including diabetes (16%), hypertension (23%) or obesity (16%). Knowledge of the primary COVID-19 symptoms and transmission routes was high, but access to hygiene and personal protection resources was low (running water 63%, hand sanitisers 53%, paper tissues 48%). Key preventive measures were not widely adopted. Knowledge, access to, and uptake of COVID-19 prevention measures were low amongst people from disadvantaged socio-economic groups. Fifteen percent of people receiving treatment for chronic diseases reported loss of access to long-term medications; 40% reported symptoms suggestive of anxiety or depression. The prevalence of unemployment rose from 9.3% to 39.4% (P < 0.001), and household income fell by 52% (P < 0.001) during the lockdown. Younger people and those from less affluent socio-economic groups were most severely impacted. Sedentary time increased by 32% and inadequate fruit and vegetable intake increased by 10% (P < 0.001 for both), while tobacco and alcohol consumption dropped by 41% and 80%, respectively (P < 0.001), during the lockdown.

conclusionsOur results identified important knowledge, access and uptake barriers to the prevention of COVID-19 in South Asia, and demonstrated major adverse impacts of the pandemic on chronic disease treatment, mental health, health-related behaviours, employment and household finances. We found important sociodemographic differences for impact, suggesting a widening of existing inequalities. Our findings underscore the need for immediate large-scale action to close gaps in knowledge and access to essential resources for prevention, along with measures to safeguard economic production and mitigate socio-economic impacts on the young and the poor.

Indexed as

COVID-19Preventative measuresSocioeconomic impactSouth AsiaSurveillance system

Identifiers

PMID33665333
PMCPMC7902538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.